Stack Genius ingredient guide
Ipriflavone
A synthetic isoflavone derivative (7-isopropoxyisoflavone) originally developed for bone research and available as a specialty supplement.
Overview
Ipriflavone is a synthetic isoflavone — specifically 7-isopropoxyisoflavone — developed in the 1960s and 70s as a candidate for bone-related research. Unlike naturally occurring soy isoflavones like genistein or daidzein, ipriflavone is a lab-made molecule with modified chemistry designed to influence bone-cell activity without acting as a classical estrogen.
In vivo, ipriflavone is metabolized into a family of related compounds, some of which mirror pathways of soy isoflavones. Its most-studied claim area is bone-density support in postmenopausal contexts. In some countries it has been sold as a prescription-style product for that indication; in the United States it is available only as a dietary supplement.
In finished products ipriflavone typically appears as a stand-alone capsule at doses of 200 or 300 mg, or in bone-support formulas alongside calcium, magnesium, vitamin D, and vitamin K. Positioning it accurately means acknowledging both its bone-research history and its specific safety signals.
Key takeaways
- Ipriflavone is a synthetic isoflavone derivative, not a soy-derived isoflavone.
- It has been studied primarily in bone-density research contexts.
- A notable clinical trial raised concerns about lowered lymphocyte counts, which drives its caution profile.
Practical guidance
What to know before adding Ipriflavone
Evidence snapshot
Trials of ipriflavone at 600 mg per day have looked at bone-density markers in postmenopausal populations. Results across studies have been mixed, and a well-known multi-year randomized trial reported reductions in lymphocyte counts in some participants without a clear bone-density advantage. That signal is why authoritative sources describe the risk-benefit picture as unfavorable for many users.
What to look for on the label
A useful label states 'ipriflavone' or the chemical name (7-isopropoxyisoflavone) explicitly, along with a per-capsule milligram dose and a total daily target. Because ipriflavone is not naturally occurring in food, source claims like 'from soy' are misleading — the ingredient is synthesized. Products that stack ipriflavone with generic 'bone blends' without disclosing doses make the calculus even harder to evaluate.
What makes a better product
Better ipriflavone products publish purity data, use unit doses (200 or 300 mg) that align with the historical research protocols, and separate ipriflavone from other bone-support actives so the user can dose intentionally. Because the ingredient has known safety signals, brands that are transparent about lymphocyte-monitoring considerations reflect more honest positioning than those that treat it as a routine mineral.
Watch-outs
The main watch-out is the lymphocyte-count signal from long-term high-dose trials, which is why clinician oversight is meaningful for anyone using ipriflavone beyond a short trial. It should not be layered on top of hormonal therapies without prescriber input. Anyone with immune-system conditions or on immune-modulating medications should specifically avoid self-guided use.
Dosing & Timing
The most studied regimen has been 200 mg three times per day (600 mg total), taken with meals. Effects on bone markers, when observed, have unfolded over many months rather than weeks. Because of the safety signals, sustained high-dose use without periodic lab monitoring is not a reasonable pattern; short trials with clinician oversight are the more responsible framing.
Safety and interaction context
The most notable safety consideration is the reported reduction in lymphocyte counts in some users on long-term high-dose regimens, which recovers after discontinuation. GI complaints have also been reported. Anyone with immune conditions, on immunosuppressive medications, or with unusual bone health situations needs medical guidance before use — and periodic lab monitoring is a reasonable expectation for extended use.
Sources
- MedlinePlus — Dietary SupplementsConsumer-facing supplement literacy framework.
- NCCIH — Using Dietary Supplements WiselyGeneral guidance on evaluating supplement safety.
- PubMed CentralEntry point for ipriflavone bone-density and safety literature.
Track products by ingredient in Stack Genius
Use Stack Genius to connect supplement products back to ingredients, spot overlap, and keep your routine organized.